314 related articles for article (PubMed ID: 24434398)
21. KDIGO Clinical Practice Guideline for Lipid Management in CKD: summary of recommendation statements and clinical approach to the patient.
Wanner C; Tonelli M;
Kidney Int; 2014 Jun; 85(6):1303-9. PubMed ID: 24552851
[TBL] [Abstract][Full Text] [Related]
22. Management of CKD-MBD in non-dialysis patients under regular nephrology care: a prospective multicenter study.
Gallieni M; De Luca N; Santoro D; Meneghel G; Formica M; Grandaliano G; Pizzarelli F; Cossu M; Segoloni G; Quintaliani G; Di Giulio S; Pisani A; Malaguti M; Marseglia C; Oldrizzi L; Pacilio M; Conte G; Dal Canton A; Minutolo R
J Nephrol; 2016 Feb; 29(1):71-8. PubMed ID: 25986389
[TBL] [Abstract][Full Text] [Related]
23. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD.
Inker LA; Astor BC; Fox CH; Isakova T; Lash JP; Peralta CA; Kurella Tamura M; Feldman HI
Am J Kidney Dis; 2014 May; 63(5):713-35. PubMed ID: 24647050
[TBL] [Abstract][Full Text] [Related]
24. [Treatment of anemia in chronic kidney disease--position statement of the Croatian Society for Nephrology, Dialysis and Transplantation and review of the KDIGO and ERPB guidelines].
Rački S; Bašić-Jukić N; Kes P; Ljutić D; Lovčić V; Prkačin I; Radić J; Vujičić B; Bubić I; Jakić M; Belavić Ž; Sefer S; Pehai M; Klarić D; Gulin M;
Acta Med Croatica; 2014 Apr; 68(2):215-21. PubMed ID: 26012163
[TBL] [Abstract][Full Text] [Related]
25. [CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). KDIGO CKD-MBD Clinical Practice Guideline].
Tsukamoto Y
Clin Calcium; 2010 Jul; 20(7):1021-7. PubMed ID: 20585180
[TBL] [Abstract][Full Text] [Related]
26. Association between Hemodialysis Patient Outcomes and Compliance with KDOQI and KDIGO Targets for Mineral and Bone Metabolism.
Djukanović L; Dimković N; Marinković J; Djurić Ž; Knežević V; Lazarević T; Ljubenović S; Marković R; Rabrenović V
Nephron; 2016; 132(3):168-74. PubMed ID: 26914677
[TBL] [Abstract][Full Text] [Related]
27. Bone evaluation in paediatric chronic kidney disease: clinical practice points from the European Society for Paediatric Nephrology CKD-MBD and Dialysis working groups and CKD-MBD working group of the ERA-EDTA.
Bakkaloglu SA; Bacchetta J; Lalayiannis AD; Leifheit-Nestler M; Stabouli S; Haarhaus M; Reusz G; Groothoff J; Schmitt CP; Evenepoel P; Shroff R; Haffner D;
Nephrol Dial Transplant; 2021 Feb; 36(3):413-425. PubMed ID: 33245331
[TBL] [Abstract][Full Text] [Related]
28. Achievements in CKD-MBD guidelines targets: is there a progress in the implementation practice?
Spasovski G; Zdravkovska V; Zabzun M; Antarorov R; Ivanovski K; Janakievska P; Neskovski J; Karceva-Sarajlia E; Panova B; Petrovska T; Zulbeari L; Masin-Spasovska J; Taleska-Matovska N; Gelev S
Int Urol Nephrol; 2012 Dec; 44(6):1791-8. PubMed ID: 22173961
[TBL] [Abstract][Full Text] [Related]
29. Improving the prognosis of patients with severely decreased glomerular filtration rate (CKD G4+): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
Eckardt KU; Bansal N; Coresh J; Evans M; Grams ME; Herzog CA; James MT; Heerspink HJL; Pollock CA; Stevens PE; Tamura MK; Tonelli MA; Wheeler DC; Winkelmayer WC; Cheung M; Hemmelgarn BR;
Kidney Int; 2018 Jun; 93(6):1281-1292. PubMed ID: 29656903
[TBL] [Abstract][Full Text] [Related]
30. Canadian Society of Nephrology commentary on the 2012 KDIGO clinical practice guideline for the management of blood pressure in CKD.
Ruzicka M; Quinn RR; McFarlane P; Hemmelgarn B; Ramesh Prasad GV; Feber J; Nesrallah G; MacKinnon M; Tangri N; McCormick B; Tobe S; Blydt-Hansen TD; Hiremath S
Am J Kidney Dis; 2014 Jun; 63(6):869-87. PubMed ID: 24725980
[TBL] [Abstract][Full Text] [Related]
31. Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: known knowns and known unknowns.
Levin A; Ahmed SB; Carrero JJ; Foster B; Francis A; Hall RK; Herrington WG; Hill G; Inker LA; Kazancıoğlu R; Lamb E; Lin P; Madero M; McIntyre N; Morrow K; Roberts G; Sabanayagam D; Schaeffner E; Shlipak M; Shroff R; Tangri N; Thanachayanont T; Ulasi I; Wong G; Yang CW; Zhang L; Robinson KA; Wilson L; Wilson RF; Kasiske BL; Cheung M; Earley A; Stevens PE
Kidney Int; 2024 Apr; 105(4):684-701. PubMed ID: 38519239
[TBL] [Abstract][Full Text] [Related]
32. [Management of bone and mineral metabolism disorders before the dialysis stage remains still perfectible. Data from the French Phosphorus and Calcium Survey Photo-Graphe].
Jean G; Daugas É; Roth H; Drueke T; Bouchet JL; Hannedouche T; London G; Fouque D
Nephrol Ther; 2017 Nov; 13(6):470-478. PubMed ID: 28843391
[TBL] [Abstract][Full Text] [Related]
33. Evidence Underlying KDIGO (Kidney Disease: Improving Global Outcomes) Guideline Recommendations: A Systematic Review.
Alseiari M; Meyer KB; Wong JB
Am J Kidney Dis; 2016 Mar; 67(3):417-22. PubMed ID: 26526035
[TBL] [Abstract][Full Text] [Related]
34. Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guidelines: a European Renal Best Practice (ERBP) commentary statement.
Goldsmith DJ; Covic A; Fouque D; Locatelli F; Olgaard K; Rodriguez M; Spasovski G; Urena P; Zoccali C; London GM; Vanholder R
Nephrol Dial Transplant; 2010 Dec; 25(12):3823-31. PubMed ID: 20829401
[TBL] [Abstract][Full Text] [Related]
35. Recommended calcium intake in adults and children with chronic kidney disease-a European consensus statement.
Evenepoel P; Jørgensen HS; Bover J; Davenport A; Bacchetta J; Haarhaus M; Hansen D; Gracia-Iguacel C; Ketteler M; McAlister L; White E; Mazzaferro S; Vervloet M; Shroff R
Nephrol Dial Transplant; 2024 Jan; 39(2):341-366. PubMed ID: 37697718
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of chronic kidney disease-mineral and bone disorder in incident peritoneal dialysis patients and its association with short-term outcomes.
Chuang SH; Wong HC; Vathsala A; Lee E; How PP
Singapore Med J; 2016 Nov; 57(11):603-609. PubMed ID: 26778726
[TBL] [Abstract][Full Text] [Related]
37. Evaluating the feasibility of the KDIGO CKD referral recommendations.
Singh K; Waikar SS; Samal L
BMC Nephrol; 2017 Jul; 18(1):223. PubMed ID: 28687072
[TBL] [Abstract][Full Text] [Related]
38. Summary of the KDIGO guideline on anemia and comment: reading between the (guide)line(s).
Drüeke TB; Parfrey PS
Kidney Int; 2012 Nov; 82(9):952-60. PubMed ID: 22854645
[TBL] [Abstract][Full Text] [Related]
39. KDOQI US Commentary on the KDIGO 2020 Clinical Practice Guideline for Diabetes Management in CKD.
Mottl AK; Alicic R; Argyropoulos C; Brosius FC; Mauer M; Molitch M; Nelson RG; Perreault L; Nicholas SB
Am J Kidney Dis; 2022 Apr; 79(4):457-479. PubMed ID: 35144840
[TBL] [Abstract][Full Text] [Related]
40. Canadian Society of Nephrology commentary on the 2012 KDIGO Clinical Practice Guideline for Anemia in CKD.
Moist LM; Troyanov S; White CT; Wazny LD; Wilson JA; McFarlane P; Harwood L; Sood MM; Soroka SD; Bass A; Manns BJ
Am J Kidney Dis; 2013 Nov; 62(5):860-73. PubMed ID: 24054466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
